No record found


* Returns not adjusted for payouts
Company Profile
GlaxoSmithKline Pakistan Limited is incorporated in Pakistan as a limited liability company. It is engaged in manufacturing and marketing of research based ethical specialties and pharmaceutical products. The Company is a subsidiary of S.R. One International B.V., incorporated in Netherlands, whereas its ultimate parent company is GlaxoSmithKline plc, UK (GSK plc).
Erum Shakir Rahim | CEO |
Lai Kuen Goh | Chairperson |
Agha Salman Taimur | Company Secretary |
CDC Share Registrar Services Limited CDC House, 99 - B, Block - B S.M.C.H.S., Main Shahra-e-Faisal Karachi
Yousuf Adil, Chartered Accountants
December
Equity Profile
Announcements
Date | Title | Document |
---|---|---|
Oct 30, 2023 | Tranmission of Quarterly Report for the Period Ended September 30, 2023 | View PDF |
Oct 24, 2023 | Financial Results for the Quarter Ended 30-09-2023 | View PDF |
Aug 28, 2023 | Transmission of Quarterly Report for the Period Ended June 30, 2023 | View PDF |
Aug 22, 2023 | GLAXO | GlaxoSmithKline Pakistan Limited Financial Results for the Half Year Ended June 30, 2023 | |
May 3, 2023 | Transmission of Annual Report for the Year Ended December 31, 2022 | View PDF |
Apr 28, 2023 | Transmission of Quarterly Report for the Period Ended March 31, 2023 | View PDF |
Apr 27, 2023 | Financial Results For The Quarter Ended March 31, 2023 | View PDF |
Mar 17, 2023 | Applied for Extension for Holding AGM for the Year ended 2022-12-31 | View PDF |
Feb 9, 2023 | Financial Results for the Year Ended December 31, 2022 | View PDF |
Oct 28, 2022 | Transmission of Quarterly Report for the Period Ended September 30, 2022 | View PDF |
Date | Title | Document |
---|---|---|
Oct 17, 2023 | Board Of Directors Meeting | View PDF |
Aug 15, 2023 | Board Meeting | View PDF |
May 24, 2023 | Certified True Copy of Resolution passed by the Shareholders in the Annual General Meeting held on May 24, 2023 | View PDF |
May 3, 2023 | Notice of Annual General Meeting | View PDF |
Apr 20, 2023 | Board of Directors Meeting | View PDF |
Apr 20, 2023 | Notice of Annual General Meeting - Prior Publication | View PDF |
Mar 27, 2023 | Approval of Extension in Time for Holding the Annual General Meeting | View PDF |
Feb 2, 2023 | Board Meeting - 4th Quarter 2022 on 9 February 2023 | View PDF |
Oct 18, 2022 | Board Meeting | View PDF |
Aug 16, 2022 | Board of Directors Meeting - August 23, 2022 | View PDF |
Date | Title | Document |
---|---|---|
Jun 2, 2023 | Material informaiton | View PDF |
Jun 2, 2023 | Change of Company Secretary | View PDF |
May 30, 2023 | Material Information - Resignation of Company Secretary | View PDF |
May 17, 2023 | Notice of Election of Directors | View PDF |
Apr 5, 2023 | RESCHEDULING OF AGM AND BOOK CLOSURE DATES | View PDF |
Nov 24, 2022 | Notice of Corporate Briefing Session 2022 | View PDF |
Sep 28, 2022 | Appointment of Non-Executive Director | View PDF |
Sep 28, 2022 | Appointment of Non-Executive Director | View PDF |
Sep 16, 2022 | GLAXO | GlaxoSmithKline Pakistan Limited REVISED | |
Sep 16, 2022 | GLAXO | GlaxoSmithKline Pakistan Limited - Panadol Information REVOKED |
Financials
All numbers in thousands (000's) except EPS
2022 | 2021 | 2020 | 2019 | |
---|---|---|---|---|
Sales | 41,841,585 | 36,660,772 | 35,090,112 | 36,581,749 |
Profit after Taxation | 2,462,892 | 5,354,409 | 3,375,240 | 3,041,123 |
EPS | 7.73 | 16.81 | 10.60 | 9.55 |
Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | |
---|---|---|---|---|
Sales | 13,770,544 | 11,860,206 | 11,399,120 | 11,925,662 |
Profit after Taxation | (69,790) | (752,393) | 430,562 | 148,664 |
EPS | (0.22) | (2.36) | 1.35 | 0.47 |

Ratios
2022 | 2021 | 2020 | 2019 | |
---|---|---|---|---|
Gross Profit Margin (%) | 17.40 | 26.56 | 21.47 | 21.08 |
Net Profit Margin (%) | 5.89 | 14.61 | 9.62 | 8.31 |
EPS Growth (%) | (54.02) | 58.58 | 10.99 | (6.65) |
PEG | (0.21) | 0.14 | 1.65 | (2.53) |
Payouts
Date | Financial Results | Details | Book Closure |
---|---|---|---|
February 28, 2022 11:32 AM | 31/12/2021(YR) | 70%(F) (D) | 19/04/2022 - 25/04/2022 |
March 10, 2021 3:45 PM | 31/12/2020(YR) | 65%(F) (D) | 21/04/2021 - 27/04/2021 |
March 11, 2020 5:58 PM | 31/12/2019(YR) | 60%(F) (D) | 15/05/2020 - 21/05/2020 |
March 4, 2019 4:53 PM | 31/12/2018(YR) | 70%(F) (D) | 18/04/2019 - 24/04/2019 |
February 27, 2018 3:59 PM | 31/12/2017(YR) | 40% (D) | 18/04/2018 - 24/04/2018 |
October 26, 2017 5:47 PM | 30/09/2017(IIIQ) | 30% (D) | 10/11/2017 - 17/11/2017 |
March 8, 2017 4:03 PM | 31/12/2016(YR) | 60% (D) | 18/04/2017 - 24/04/2017 |
March 30, 2016 3:13 PM | 31/12/2015(YR) | 40% (D) | 20/04/2016 - 27/04/2016 |
February 25, 2015 3:51 PM | 31/12/2014(YR) | 50% (D) | 16/04/2015 - 23/04/2015 |
February 7, 2014 3:24 PM | 31/12/2013(YR) | 35% (D) - 10% (B) | 21/04/2014 - 28/04/2014 |